These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 25763727)

  • 1. Cancer immunotherapy: imaging assessment of novel treatment response patterns and immune-related adverse events.
    Kwak JJ; Tirumani SH; Van den Abbeele AD; Koo PJ; Jacene HA
    Radiographics; 2015; 35(2):424-37. PubMed ID: 25763727
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer Imaging in Immunotherapy.
    Eleneen Y; Colen RR
    Adv Exp Med Biol; 2017; 995():141-153. PubMed ID: 28321816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Response criteria for immunotherapy and the radiologic patterns of immune-related adverse events.
    Elsherif SB; Anderson M; Chaudhry AA; Kumar SP; Gopireddy DR; Lall C; Bhosale PR
    Eur J Radiol; 2022 Jan; 146():110062. PubMed ID: 34890935
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Imaging the immune response to monitor tumor immunotherapy.
    Wang Q; Ornstein M; Kaufman HL
    Expert Rev Vaccines; 2009 Oct; 8(10):1427-37. PubMed ID: 19803763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human cancer detection and immunotherapy with conjugated and non-conjugated monoclonal antibodies.
    Bodey B; Siegel SE; Kaiser HE
    Anticancer Res; 1996; 16(2):661-74. PubMed ID: 8687112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cancer Imaging in Immunotherapy.
    Ayoub M; Eleneen Y; Colen RR
    Adv Exp Med Biol; 2020; 1244():309-324. PubMed ID: 32301025
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunotherapy in oncology: a new challenge for radiologists.
    Bustos Fiore A; Gutiérrez AB; Acosta LG; Segura Cros C; Ramos de la Rosa R
    Radiologia (Engl Ed); 2019; 61(2):134-142. PubMed ID: 30580817
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abdominal CT manifestations of adverse events to immunotherapy: a primer for radiologists.
    Pourvaziri A; Parakh A; Biondetti P; Sahani D; Kambadakone A
    Abdom Radiol (NY); 2020 Sep; 45(9):2624-2636. PubMed ID: 32451672
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endocrine side effects induced by immune checkpoint inhibitors.
    Corsello SM; Barnabei A; Marchetti P; De Vecchis L; Salvatori R; Torino F
    J Clin Endocrinol Metab; 2013 Apr; 98(4):1361-75. PubMed ID: 23471977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical evaluation of "immunoaugmentative therapy (IAT)": an unconventional cancer treatment.
    Pfeifer BL; Jonas WB
    Integr Cancer Ther; 2003 Jun; 2(2):112-9. PubMed ID: 15035898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunotherapy-Related Imaging Findings in Patients with Gynecological Malignancies: What Radiologists Need to Know.
    Russo L; Avesani G; Gui B; Trombadori CML; Salutari V; Perri MT; Di Paola V; Rodolfino E; Scambia G; Manfredi R
    Korean J Radiol; 2021 Aug; 22(8):1310-1322. PubMed ID: 34047505
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurological sequelae of cancer immunotherapies and targeted therapies.
    Wick W; Hertenstein A; Platten M
    Lancet Oncol; 2016 Dec; 17(12):e529-e541. PubMed ID: 27924751
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Imaging of Cancer Immunotherapy: Current Approaches and Future Directions.
    Nishino M; Hatabu H; Hodi FS
    Radiology; 2019 Jan; 290(1):9-22. PubMed ID: 30457485
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of cancer immunotherapy outcome in terms of the immune response time features.
    Rodríguez-Pérez D; Sotolongo-Grau O; Espinosa Riquelme R; Sotolongo-Costa O; Santos Miranda JA; Antoranz JC
    Math Med Biol; 2007 Sep; 24(3):287-300. PubMed ID: 17652107
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer immunotherapy using tumor cryoablation.
    Sidana A
    Immunotherapy; 2014; 6(1):85-93. PubMed ID: 24341887
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Measurement of tumour response to cancer treatment: morphologic imaging role].
    Ollivier L; Leclère J; Thiesse P; Di Stefano D; Vincent C
    Bull Cancer; 2007 Feb; 94(2):171-7. PubMed ID: 17337386
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bio-immunotherapy for cancer in experimental studies and clinical application: current status and future challenges.
    Shen RN; Lu L; Kaiser HE; Broxmeyer HE
    In Vivo; 1994; 8(5):643-52. PubMed ID: 7727711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer treatment: what's ahead?
    Parvez T
    J Coll Physicians Surg Pak; 2005 Nov; 15(11):738-45. PubMed ID: 16300718
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune Modulation Therapy and Imaging: Workshop Report.
    Shields AF; Jacobs PM; Sznol M; Graham MM; Germain RN; Lum LG; Jaffee EM; de Vries EGE; Nimmagadda S; Van den Abbeele AD; Leung DK; Wu AM; Sharon E; Shankar LK
    J Nucl Med; 2018 Mar; 59(3):410-417. PubMed ID: 28818991
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patterns of relapse and response to retreatment in patients with metastatic melanoma or renal cell carcinoma who responded to interleukin-2-based immunotherapy.
    Lee DS; White DE; Hurst R; Rosenberg SA; Yang JC
    Cancer J Sci Am; 1998; 4(2):86-93. PubMed ID: 9532410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.